Gene · 51135
Papers3,419
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
401 to 420 of 3,419
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Structural and non-structural proteins in SARS-CoV-2: potential aspects to COVID-19 treatment or prevention of progression of related diseases. | Cell Commun Signal | 2023 | 37189112 | PubTator, text mining | PubMed |
| Protein kinases: drug targets for immunological disorders. | Nat Rev Immunol | 2023 | 37188939 | PubTator, text mining | PubMed |
| An overview of glioblastoma multiforme and temozolomide resistance: can LC-MS-based proteomics reveal the fundamental mechanism of temozolomide resistance? | Front Oncol | 2023 | 37182181 | PubTator, text mining | PubMed |
| Biologic Mechanisms of Macrophage Phenotypes Responding to Infection and the Novel Therapies to Moderate Inflammation. | Int J Mol Sci | 2023 | 37176064 | PubTator, text mining | PubMed |
| Role of Coxsackievirus B3-Induced Immune Responses in the Transition from Myocarditis to Dilated Cardiomyopathy and Heart Failure. | Int J Mol Sci | 2023 | 37175422 | PubTator, text mining | PubMed |
| Deciphering the intrinsic dynamics of unphosphorylated IRAK4 kinase bound to type I and type II inhibitors. | Comput Biol Med | 2023 | 37172355 | PubTator, text mining | PubMed |
| Paralog-specific signaling by IRAK1/4 maintains MyD88-independent functions in MDS/AML. | Blood | 2023 | 37172199 | PubTator, text mining | PubMed |
| Design, synthesis and pharmacological evaluation of 2,3-dihydrobenzofuran IRAK4 inhibitors for the treatment of diffuse large B-cell lymphoma. | Eur J Med Chem | 2023 | 37163947 | PubTator, text mining | PubMed |
| Interferon-lambda: New role in intestinal symptoms of COVID-19. | World J Gastroenterol | 2023 | 37155525 | PubTator, text mining | PubMed |
| The tick saliva peptide HIDfsin2 promotes the tick-borne virus SFTSV replication in vitro by enhancing p38 signal pathway. | Arch Toxicol | 2023 | 37148319 | PubTator, text mining | PubMed |
| High-risk factors associated with refractory childhood bacterial meningitis in Southwest China. | BMC Pediatr | 2023 | 37147568 | PubTator, text mining | PubMed |
| Comparative analyses of bat genomes identify distinct evolution of immunity in Old World fruit bats. | Sci Adv | 2023 | 37146151 | PubTator, text mining | PubMed |
| Coinfections in the lung: How viral infection creates a favorable environment for bacterial and fungal infections. | PLoS Pathog | 2023 | 37141196 | PubTator, text mining | PubMed |
| Discovery of grey matter lesion-related immune genes for diagnostic prediction in multiple sclerosis. | PeerJ | 2023 | 37128203 | PubTator, text mining | PubMed |
| Paradoxical activation of chronic lymphocytic leukemia cells by ruxolitinib in vitro and in vivo. | Front Oncol | 2023 | 37114129 | PubTator, text mining | PubMed |
| A Bird's Eye View of Various Cell-Based Biomimetic Nanomedicines for the Treatment of Arthritis. | Pharmaceutics | 2023 | 37111636 | PubTator, text mining | PubMed |
| Phytochemicals of Withania somnifera as a Future Promising Drug against SARS-CoV-2: Pharmacological Role, Molecular Mechanism, Molecular Docking Evaluation, and Efficient Delivery. | Microorganisms | 2023 | 37110423 | PubTator, text mining | PubMed |
| Hidradenitis Suppurativa and JAK Inhibitors: A Review of the Published Literature. | Medicina (Kaunas) | 2023 | 37109759 | PubTator, text mining | PubMed |
| IRAK2, an Immune and Radiation-Response Gene, Correlates with Advanced Disease Features but Predicts Higher Post-Irradiation Local Control in Non-Metastatic and Resected Oral Cancer Patients. | Int J Mol Sci | 2023 | 37108068 | PubTator, text mining | PubMed |
| Human Genes Involved in the Interaction between Host and Gut Microbiome: Regulation and Pathogenic Mechanisms. | Genes (Basel) | 2023 | 37107615 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51135/papers?page=21